Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to $1.2 million.

  • Milestone Scientific's Accumulated Expenses fell 692.78% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 692.78%. This contributed to the annual value of $1.8 million for FY2024, which is 1882.64% up from last year.
  • As of Q3 2025, Milestone Scientific's Accumulated Expenses stood at $1.2 million, which was down 692.78% from $1.4 million recorded in Q2 2025.
  • Milestone Scientific's 5-year Accumulated Expenses high stood at $1.8 million for Q4 2024, and its period low was $952448.0 during Q2 2022.
  • In the last 5 years, Milestone Scientific's Accumulated Expenses had a median value of $1.3 million in 2024 and averaged $1.3 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 7190.14% in 2021, then plummeted by 3150.62% in 2022.
  • Quarter analysis of 5 years shows Milestone Scientific's Accumulated Expenses stood at $1.4 million in 2021, then dropped by 20.63% to $1.1 million in 2022, then surged by 34.39% to $1.5 million in 2023, then grew by 18.83% to $1.8 million in 2024, then plummeted by 34.32% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.4 million for Q2 2025, and $1.3 million during Q1 2025.